ALS beats twice downgraded guidance

The market has championed ALS’s first half results this week after the testing service and labs provider produced results that were 6% ahead of twice downgraded company estimates.

Gas
Source: Bloomberg

Half-on-half comparison sees ALS's underlying net profit down 33% to $68 million, as the demand from its core material and energy division sees more pain.

The half year numbers did not provide specific guidance numbers, just an outlook statement clearly showing that the fourth quarter remains difficult to forecast, given the impact of the traditional Christmas shutdown.

I remain short in ALS Ltd for the following reasons:

  1. The Material and Energy divisions are likely to see further downsides. Discretionary spending in exploration and field development is slowing globally and demand for lab testing services are directly impacted by this decline.
  2. Tax rates are also etching out profits, as the company sees a return from the divestment of the Reward Distribution business.
  3. On a multiple basis ALS Ltd remains elevated, even after falling for most of 2014. At 20.1 times earnings it is still trading at a premium to peers (peers range from 14.6 to 17.9 times earnings). If volumes in materials and energy were to return, the price would be justified. However, on current market conditions, this looks unlikely.

 

Denna information har sammanställts av IG, ett handelsnamn för IG Markets Limited. Utöver friskrivningen nedan innehåller materialet på denna sida inte ett fastställande av våra handelspriser, eller ett erbjudande om en transaktion i ett finansiellt instrument. IG accepterar inget ansvar för eventuella åtgärder som görs eller inte görs baserat på detta material eller för de följder detta kan få. Inga garantier ges för riktigheten eller fullständigheten av denna information. Någon person som agerar på informationen gör det således på egen risk. Materialet tar inte hänsyn till specifika placeringsmål, ekonomiska situationer och behov av någon specifik person som får ta del av detta. Det har inte upprättats i enlighet med rättsliga krav som ställs för att främja oberoende investeringsanalyser utan skall betraktas som marknadsföringsmaterial.